Meet your national and state pharmacology credit requirements with recordings from NPACE’s live pharmacology conferences. These sessions will help you improve or maintain prescribing skills as well as stay current with the latest in pharmacotherapeutics. 

You may filter by category, such as women’s health or diabetes, alphabetically or by date. Click the “View” button to read the Course Description, Course Objectives, Speaker information, CNE Information and Disclosures. 

Like what you see? Click “Register” and follow instructions to view the video recording for up to one year. Successful completion of the post-test is required for CE units to be granted.

On-Demand Pharmacology CE

Search by Type
Sort By

73 Results

  • In accordance with the Medication Access and Training Expansion (MATE) Act, beginning June 7, 2023, all providers who are registered with the DEA are required to complete 8 hours of training on the treatment and management of patients with opioid and other substance use disorders. This bundle fully satisfies this one-time requirement. 

    Total Credits: 9.0 contact hours; 8.5 are pharmacology

    Expiration Date: June 30, 2024


  • Merck Grant Funded Program

    The overall goal of this program is to address the barriers in vaccination uptake and integration. 

    Credits: 1.0 contact hours; 1.0 are Pharmacology

  • Adolescent substance use has followed familiar trends for several decades with alcohol, nicotine, and cannabis leading other drugs in popularity. After several years of declining nicotine use, primarily via combustible cigarettes, recent data suggests a resurgence of nicotine use, primarily via e-cigarettes as well as a marked increase in cannabis use, likely corresponding with legalization efforts. Additionally, there has been an increase in hallucinogen use and the dangers of opioid use have heightened due to the rise of illicit fentanyl being brought in from outside the United States. This lecture will review the most recent Monitoring the Future study and discuss implications of adolescent substance use trends on healthcare providers.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    Expiration Date: June 30, 2024

  • Influenza and COVID-19 are both respiratory illnesses that can cause serious complications, especially in high-risk populations. Nurse practitioners play a key role in the diagnosis and treatment of influenza and COVID-19 infections. This presentation will evaluate the different types of antiviral medications and their pharmacologic features. Patient populations who are most likely to benefit from antiviral therapy will be reviewed. This presentation will examine the most up to date evidence related to efficacy and safety of antivirals for influenza and COVID-19, and provide an approach to the appropriate use of these medications in clinical practice.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology

  • In 2019, the Infectious Disease Society of America and American Thoracic Society published updated recommendations for managing patients with community-acquired pneumonia (CAP) generating new considerations for inpatient and outpatient practitioners. This presentation will assess emerging literature influencing the optimal pharmacologic management of CAP such as, changing etiologic trends, patient-specific factors, outcomes evidence, and risk factors for adverse drug reactions.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology

  • This session will provide the nurse practitioner with information regarding common pathogens implicated in AECB and community acquired pneumonia in the patient with underlying co-morbidities such as asthma, COPD and alcohol abuse.  Current recommendations regarding antimicrobial treatment options will be reviewed in detail.  National recommendations for obtaining chest x-ray and sputum for gram staining will also be discussed.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology

  • Atrial fibrillation (AF) remains the most common heart arrhythmia in the general population and is associated with significant morbidity and mortality. Appropriate identification and treatment are critical to prevent potential devastating sort-and long-term outcomes. Practitioners in all areas of practice will encounter patients with various stages of AF, and therefore must be able to identify, classify and treat this common arrhythmia. This session will focus on the classification of AF, identification and various treatment and preventative options.

    Credits: 1.50 contact hours; 0.75 are pharmacology
  • This presentation will discuss common laboratory studies utilizing a case-based method. Then review decision-making strategies including the selection of the most appropriate tests for the clinical presentation, based on the current evidence. Lastly, explore the interpretation of the potential findings and develop the best treatment plans as well as any necessary follow-up that may be needed based on the findings.

    Credits: 1.00 contact hours; 0.25 are pharmacology
    Release Date: March 1, 2021
    Expiration Date: June 30, 2024
  • Pfizer Grant Funded Program

    The overall goal of this program is to deliver targeted educational interventions to (1) improve health outcomes among outpatients with COVID-19 by building skills, knowledge, and competencies of providers that serve them, and (2) address provider knowledge gaps related to Drug-to-Drug Interactions (DDIs) in COVID-19 treatment.

    Credits: 1.0 contact hours; 1.0 are pharmacology

  • At NPACE Pharmacology Update & Primary care Conference you will fulfill your professional development and licensure needs, and access priceless context, insights, and real-world understanding of complex healthcare issues. Each session emphasizes relevant and evidence-based clinical knowledge as well as offers guidance by seasoned speakers connected to today’s practice and is open to interaction and discussion.

    Credits: 17 credits; 10.80 are pharmacology